4//SEC Filing
Cobb Stuart 4
Accession 0001404644-25-000046
CIK 0001404644other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:43 PM ET
Size
13.2 KB
Accession
0001404644-25-000046
Insider Transaction Report
Form 4
Neurogene Inc.NGNE
Cobb Stuart
Chief Scientific Officer
Transactions
- Sale
Common Stock
2025-05-14$15.15/sh−6,797$103,003→ 20,794 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on February 6, 2025.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.78 to $15.75. The reporting person undertakes to provide Neurogene Inc. (the "Company"), any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Issuer
Neurogene Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001994301
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:43 PM ET
- Size
- 13.2 KB